# The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma

> **NCT06355427** · PHASE2,PHASE3 · RECRUITING · sponsor: **Mara Veenstra, MD** · enrollment: 81 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DRUG:** [18F]F-FAPI PET-CT

## Key facts

- **NCT ID:** NCT06355427
- **Lead sponsor:** Mara Veenstra, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355427, "The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06355427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*